对上海市青浦区基本药物目录中非传染性疾病药品的价格水平研究

Empirical research on the price level of drugs for non-communicable diseases in basic drug list of Shanghai Qingpu District

目的:评估上海市青浦区基本药物目录中治疗非传染性疾病(non-communicable diseases,NCDs)药品的价格水平,为促进社区基本药物价格合理性提供实证依据和政策建议。方法:借鉴WHO/HAI标准调查法,选用购买力平价系数,计算47种通用名药品的中位价格比(median price ratio,MPR)。结果:47种调查药品MPR为7.48,其中原研药和最低价仿制药MPR分别为16.26和3.33。原研药的价格、区间差异大于最低价仿制药,它们的MPR的比率中位值为2.86。沙丁胺醇的原研药MPR小于仿制药。结论:目录中社区NCDs基本药物价格水平偏高,需要通过一系列的政策干预使原研药和大部分仿制药达到合理的价格水平。

Objective:To evaluate the price level of medicines for non-communicable diseases in basic medicine list of Shanghai Qingpu district,so as to provide solid evidences and suggestions for the promotion of price rationality of basic medicines in the community.Methods:The median price ratio(MPR)of 47 nomenclature medicine was calculated by purchasing power parity coefficient with the standard survey method recommended by WHO/HAI.Results:The MPR of 47 nomenclature medicines in the investigation was 7.48,the MPR of original brand(OB)and the lowest-price me-too medicines(LPMMs)were 16.26 and 3.33,respectively.The price and the difference of OB were greater than those of the LPMMs,and median rate of their MPR was 2.86.The MPR of OB salbutamol was less than that of LPMM salbutamol.Conclusion:The price level of the community NCDs basic medicines is relatively high.A series of policy intervention is required to achieve a reasonable price level of the OB and most of LPMMs.